ImmunoLogik GmbH
Industry / private company
Location:
Berlin,
Germany (DE)
Novel, orally available immune modulator MP1032 with pan-variant anti-SARS-CoV-2 and anti-inflammatory activity (2022)
Schumann S, Setz C, Schulz P, Kaiser A, Schubert U, Brysch W
Conference contribution
Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2 (2021)
Große M, Ruetalo N, Layer M, Hu D, Businger R, Rheber S, Setz C, et al.
Journal article